NASDAQ: MDVLMedavail Holdings Inc Stock
$2.25+0.01 (+0.45%)
Updated Dec 8, 2023
MDVL Price
$2.25
Fair Value Price
$587.65
Market Cap
$3.63M
52 Week Low
$1.91
52 Week High
$33.65
P/E
-0.08x
P/B
0.16x
P/S
0.93x
PEG
N/A
Dividend Yield
N/A
Revenue
$23.84M
Earnings
-$46.00M
Gross Margin
6.7%
Operating Margin
-188.96%
Profit Margin
-193%
Debt to Equity
0.3
Operating Cash Flow
-$32M
Beta
0.76
Next Earnings
Dec 11, 2023
Ex-Dividend
N/A
Next Dividend
N/A
MDVL Overview
MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. It also owns and operates SpotRx, a retail pharmacy platform. As of December 31, 2021, the company had 81 MedCenter kiosks. MedAvail Holdings, Inc. is headquartered in Mississauga, Canada.
Zen Score
–
Industry Average (24)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MDVL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MDVL ($2.25) is undervalued by 99.62% relative to our estimate of its Fair Value price of $587.65 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MDVL ($2.25) is significantly undervalued by 99.62% relative to our estimate of its Fair Value price of $587.65 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MDVL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MDVL due diligence checks available for Premium users.
Be the first to know about important MDVL news, forecast changes, insider trades & much more!
MDVL News
Valuation
MDVL fair value
Fair Value of MDVL stock based on Discounted Cash Flow (DCF)
Price
$2.25
Fair Value
$587.65
Undervalued by
99.62%
MDVL ($2.25) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MDVL ($2.25) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MDVL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MDVL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.08x
Industry
-6.54x
Market
31.32x
MDVL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.16x
Industry
1.01x
MDVL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MDVL's financial health
Profit margin
Revenue
$405.0k
Net Income
-$5.8M
Profit Margin
-1,429.9%
MDVL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MDVL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$29.9M
Liabilities
$6.9M
Debt to equity
0.3
MDVL's short-term assets ($27.05M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MDVL's short-term assets ($27.05M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MDVL's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MDVL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.4M
Investing
-$41.0k
Financing
-$17.0k
MDVL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MDVL vs Pharmaceutical Retailer Stocks
Medavail Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.